While the study shows clusterin suppresses aggregation of multiple disease-relevant proteins, the molecular basis for this broad specificity versus any selective mechanisms is unclear. This knowledge gap limits understanding of clusterin's therapeutic potential across different proteinopathies. Gap type: unexplained_observation Source paper: Structural analyses define the molecular basis of clusterin chaperone function. (2025, Nature structural & molecular biology, PMID:40781479)
Landscape Summary: What determines clusterin's selectivity for different misfolded proteins (amyloid-β, tau, α-synuclein)? is a 0.79 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What determines clusterin's selectivity for different misfolded proteins (amyloid-β, tau, α-synuclein)? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: